ask="4.29"
ask_size="200"
average_daily_volume="160567"
bid="3.60"
bid_size="1000"
book_value="1.98"
change="+0.00"
change_from_200_day_moving_average="-0.61"
change_from_50_day_moving_average="-0.18"
change_from_52_week_high="-4.54"
change_From_52_week_low="0.39"
change_in_percent="+0.00%"
close="3.61"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-2.39"
ebitda="-35.85M"
eps_estimate_current_year="-2.30"
eps_estimate_next_quarter="-0.50"
eps_estimate_next_year="-2.13"
ex_dividend_date="N/A"
float_shares="8580000"
high="3.80"
high_52_weeks="8.15"
last_trade_date="12/30/2016"
last_trade_price="3.61"
last_trade_size="2700"
last_trade_time="4:00pm"
low="3.34"
low_52_weeks="3.22"
market_capitalization="67.33M"
moving_average_200_day="4.22"
moving_average_50_day="3.79"
name="Catabasis Pharmaceuticals
Inc."
notes="N/A"
one_year_target_price="18.00"
open="3.34"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="-14.37%"
percent_change_from_50_day_moving_average="-4.63%"
percent_change_from_52_week_high="-55.71%"
percent_change_from_52_week_low="+12.11%"
previous_close="3.61"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="1.83"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="18652000"
short_ratio="2.34"
stock_exchange="NGM"
symbol="CATB"
volume="258896"
weeks_range_52="3.22 - 8.15"
